Corton Capital’s Instil Bio TIL Stock Holding History

Corton Capital’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,098	Closed	-$106K	–	373
2022 Q3	$106K	Buy	1,098 +227	+26%	+$26K	0.13%	227
2022 Q2	$80K	Buy	+871	New	+$123K	0.08%	296

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corton Capital's TIL Position: Q4 2022 in Review

Corton Capital sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 1,098 shares — an estimated $106K sold.

Corton Capital first reported a position in TIL in Q2 2022 and held it in 2 quarters. The position peaked at $106K in Q3 2022. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

Corton Capital reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
Corton Capital sold 1,098 Instil Bio shares in Q4 2022, an estimated $106K.
Corton Capital first reported a position in Instil Bio in Q2 2022 and held it in 2 quarters.
Corton Capital's Instil Bio position peaked at $106K in Q3 2022.
78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Corton Capital's 13F filing for Q4 2022, filed 14 Feb 2023.